Patents by Inventor Niels Korsgaard

Niels Korsgaard has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Use of 1-centchroman for the manufacture of a pharmaceutical composition for the treatment of obesity
    Patent number: 6008242
    Abstract: The present invention provides novel uses of compounds of general formula I ##STR1## wherein R.sup.1, R.sup.4 and R.sup.5 are individually hydrogen, hydroxy, halogen, trifluoromethyl, lower alkyl, lower alkoxy or (tertiary amino)(lower alkoxy); and R.sup.2 and R.sup.3 are individually hydrogen or lower alkyl, or as a pharmaceutically acceptable salt thereof in combination with a pharmaceutically acceptable carrier for the manufacture of a pharmaceutical composition for the treatment or-prophylaxis of obesity.
    Type: Grant
    Filed: January 11, 1996
    Date of Patent: December 28, 1999
    Assignee: Novo Nordisk A/S
    Inventors: Niels Korsgaard, Michael Shalmi, Steven Bain, Birgitte Hjort Guldhammer
  • Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for the treatment or prophylaxis of idiopathic or physiologic gynaecomastia
    Patent number: 5919812
    Abstract: The present invention provides novel uses of compounds of general formula I ##STR1## wherein R1, R4 and R5 are individually hydrogen, hydroxy, halogen, trifluoromethyl, lower alkyl, lower alkoxy or (tertiary amino)(lower alkoxy); and R2 and R3 are individually hydrogen or lower alkyl, or as a pharmaceutically acceptable salt thereof in combination with a pharmaceutically acceptable carrier for the manufacture of a pharmaceutical composition for the treatment or prophylaxis of idiopathic or physiologic gynaecomastia.
    Type: Grant
    Filed: March 4, 1997
    Date of Patent: July 6, 1999
    Assignee: Novo Nordisk A/S
    Inventors: Niels Korsgaard, Michael Shalmi, Birgitte Hjort Guldhammer
  • Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for vasodilatory treatment or prophylaxis
    Patent number: 5886021
    Abstract: The present invention provides novel uses of compounds of general formula I ##STR1## wherein R.sup.1, R.sup.4 and R.sup.5 are individually hydrogen, hydroxy, halogen, trifluoromethyl, lower alkyl, lower alkoxy or (tertiary amino)(lower alkoxy); and R.sup.2 and R.sup.3 are individually hydrogen or lower alkyl, or as a pharmaceutically acceptable salt thereof in combination with a pharmaceutically acceptable carrier for the manufacture of a pharmaceutical composition for vasodilatory treatment or prophylaxis.
    Type: Grant
    Filed: August 18, 1997
    Date of Patent: March 23, 1999
    Assignee: Novo Nordisk A/S
    Inventors: Niels Korsgaard, Michael Shalmi, Jan Ulrik Weis, Birgitte Hjort Guldhammer
  • Prostatic carcinoma
    Patent number: 5883118
    Abstract: The present invention provides novel uses of compounds of general formula I ##STR1## wherein R.sup.1, R.sup.4 and R.sup.5 are individually hydrogen, hydroxy, halogen, trifluoromethyl, lower alkyl lower alkoxy or (tertiary amino)(lower alkoxy); and R.sup.2 and R.sup.
    Type: Grant
    Filed: July 11, 1996
    Date of Patent: March 16, 1999
    Assignee: Nova Nordisk A/S
    Inventors: Michael Shalmi, Niels Dyhr Christensen, Niels Korsgaard, Birgitte Hjort Guldhammer
  • Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for the treatment or prevention of cerebral degenerative disorders
    Patent number: 5827873
    Abstract: The present invention provides novel uses of compounds of general formula I ##STR1## wherein R.sup.1, R.sup.4 and R.sup.5 are individually hydrogen, hydroxy, halogen, trifluoromethyl, lower alkyl, lower alkoxy or (tertiary amino)(lower alkoxy); and R.sup.2 and R.sup.3 are individually hydrogen or lower alkyl, or as a pharmaceutically acceptable salt thereof in combination with a pharmaceutically acceptable carrier for the manufacture of a pharmaceutical composition for the treatment or prophylaxis of cerebral degenerative disorders.
    Type: Grant
    Filed: January 10, 1997
    Date of Patent: October 27, 1998
    Assignee: Novo Nordisk A/S
    Inventors: Niels Korsgaard, Michael Shalmi, Birgitte Hjort Guldhammer
  • 2-Phenyl-3-Azoylbenzothiophene for lowering intraocular pressure
    Patent number: 5798369
    Abstract: The present invention provides a novel use of a compound of formula I ##STR1## or a pharmaceutically and/or physiologically acceptable salt or solvate thereof for the manufacture of a pharmaceutical composition useful for lowering intraocular pressure.
    Type: Grant
    Filed: July 7, 1997
    Date of Patent: August 25, 1998
    Assignee: Novo Nordisk A/S
    Inventors: Niels Korsgaard, John Romer
  • Atrophy of skin/mucous membrane
    Patent number: 5747059
    Abstract: The present invention provides novel uses of compounds of general formula I: ##STR1## wherein R.sup.1, R.sup.4 and R.sup.5 are individually hydrogen, hydroxy, halogen, trifluoromethyl, lower alkyl, lower alkoxy or (tertiary amino)(lower alkoxy); and R.sup.2 and R.sup.3 are individually hydrogen or lower alkyl, or as a pharmaceutically acceptable salt thereof in combination with a pharmaceutically acceptable carrier for the manufacture of a pharmaceutical composition for the treatment or prophylaxis of atrophy of skin and/or mucous membranes.
    Type: Grant
    Filed: July 11, 1996
    Date of Patent: May 5, 1998
    Assignee: Novo Nordisk A/S
    Inventors: Niels Korsgaard, James Robertson Piggott, Virender Mohan Labroo, Steven Bain
  • Benign prostatic hypertrophy
    Patent number: 5726202
    Abstract: The present invention provides novel uses of compounds of general formula I ##STR1## wherein R.sup.1, R.sup.4 and R.sup.5 are individually hydrogen, hydroxy, halogen, trifluoromethyl, lower alkyl, lower alkoxy or (tertiary amino) (lower alkoxy); and R.sup.2 and R.sup.
    Type: Grant
    Filed: July 11, 1996
    Date of Patent: March 10, 1998
    Assignee: Novo Nordisk A/S
    Inventors: Michael Shalmi, Niels Dyhr Christensen, Niels Korsgaard, Birgitte Hjort Guldhammer
  • Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for the treatment or prophylaxis of cerebral degenerative disorders
    Patent number: 5696149
    Abstract: The present invention provides novel uses of compounds of general formula I ##STR1## wherein R.sup.1, R.sup.4 and R.sup.5 are individually hydrogen, hydroxy, halogen, trifiuoromethyl, lower alkyl, lower alkoxy or (tertiary amino)(lower alkoxy); and R.sup.2 and R.sup.3 are individually hydrogen or lower alkyl, or as a pharmaceutically acceptable salt thereof in combination with a pharmaceutically acceptable carrier for the manufacture of a pharmaceutical composition for the treatment or prophylaxis of cerebral degenerative disorders.
    Type: Grant
    Filed: January 11, 1996
    Date of Patent: December 9, 1997
    Assignee: Novo Nordisk A/S
    Inventors: Niels Korsgaard, Michael Shalmi, Birgitte Hjort Guldhammer